Über das Unternehmen
- Firmenname (rechtlich): OMGENE LIFE SCIENCES PRIVATE LIMITED
- Registrierungsland: India
- Adresse: 333/334, GIDC Makarpura,, Makarpura GIDC, Vadodara, Gujarat
- Anzahl der Mitarbeiter: 100 - 249
Beschreibung:
Omgene Life Sciences Pvt. Ltd., an R&D-based company incorporated in March 2011, has operated in the biopharmaceutical space since its founding by Dr. A.L. Prasad, a highly skilled, experienced pharmaceutical technocrat with around 30 years of industrial track record, leading an R&D team of more than 100 highly skilled professionals. Omgene is a fast-growing Indian company engaged in developing, manufacturing and marketing peptides, oligonucleotides, semi-synthetic and synthetic APIs, and recombinant molecules.
Geschäftsaktivitäten
Pharmazeutische Wirkstoffe (API)
API-Hersteller
Vertrags- & Outsourcing-Dienstleistungen
API-Hersteller
Produktionsanlagen & Betriebstechnik
API-Hersteller
Original-Wirkstoffe
API-Hersteller
Absatzmärkte
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Western Asia: United Arab Emirates, Armenia, Azerbaijan, Bahrain
Hauptprodukte/-dienstleistungen
- Pharmazeutische Wirkstoffe (API): Triptorelin Acetate, Fulvestrant, Liraglutide, Binimetinib, Omadacycline, Erdafitinib, Everolimus, Ixazomib Citrate, Midostaurin, Sugammadex Sodium, Tirzepatide, Vasopressin, Cetrorelix Acetate, Degarelix Acetate, Carbetocin, Etelcalcetide, Ganirelix Acetate, Lanreotide Acetate, Leuprolide Acetate, Linaclotide, Octreotide Acetate, Oxytocin Acetate, Pentetreotide, Plecanatide, Terlipressin Acetate, Rezafungin, Apremilast, Bedaquiline Fumarate, Brivaracetam, Crisaborole, Deutetrabenazine, Ribociclib Succinate, Mebendazole (Micronized), Nintedanib Esylate, Nitisinone, Obeticholic acid, Rufinamide, Sarecycline Hydrochloride, Selexipag, Tofacitinib Citrate, Vismodegib
- Vertrags- & Outsourcing-Dienstleistungen: Complex Semi-synthetic APIs
Unsere Produkte & Dienstleistungen
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Certifications
Proofs
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen